共 45 条
- [1] Tuffanelli D.L., Winkelmann R.K., Systemic scleroderma. A clinical study of 727 cases, Arch Dermatol, 84, pp. 359-371, (1961)
- [2] Tuffanelli D.L., Winkelmann R.K., Diffuse systemic scleroderma. A comparison with acrosclerosis, Ann Intern Med, 57, pp. 198-203, (1962)
- [3] Barnett A.J., Coventry D.A., Scleroderma: 1. clinical features, course of illness and response to treatment in 61 cases, Med J Aust, 1, pp. 992-1001, (1969)
- [4] Rowell N.R., The prognosis of systemic sclerosis, Br J Dermatol, 95, pp. 57-60, (1976)
- [5] Barnett A.J., Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 cases, Med J Aust, 2, pp. 129-134, (1978)
- [6] Livingston J.Z., Scott T.E., Wigley F.M., Anhalt G.J., Bias W.B., McLean R.H., Hochberg M.C., Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets, J Rheumatol, 14, pp. 512-518, (1984)
- [7] Cassani F., Tosti A., Bianchi F.B., Fusconi M., Selleri L., Baffoni L., Veronesi S., Volta U., Lenzi M., Pisi E., Clinical subsets of scleroderma: relevance of fluorescent and precipitating anti-nuclear antibodies, Clin Exp Rheum, 5, pp. 23-28, (1987)
- [8] Masi A., D'Angelo W.A., Epidemiology of fatal systemic sclerosis (diffuse scleroderma) A 15-year survey in Baltimore, Ann Intern Med, 66, pp. 870-875, (1967)
- [9] Medsger T.A., Masi A.T., Epidemiology of systemic sclerosis (scleroderma), Ann Intern Med, 74, pp. 714-721, (1971)
- [10] Medsger T.A., Masi A.T., Rodnan G.P., Benedek T.G., Robinson H., Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients, Ann Intern Med, 75, pp. 369-376, (1971)